Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
O.E. Dahl
Observed names:
Dahl OE,
Dahl, O,
O Dahl,
O E Dahl,
O. E. Dahl,
O.E. DAHL,
OE Dahl
show all 7
Observed institutions:
Oslo University Hospital,
Innlandet Hospital Trust,
University of Perugia,
Drammen Hospital,
Diakonhjemmet Hospital,
Thrombosis Research Institute
show all 6
OpenAlex ID:
A5112900808
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
2007
·
B.I. ERIKSSON
, O.E. DAHL
, et al.
·
Journal of Thrombosis and Haemostasis
·
978
PDF
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
2004
·
B.I. ERIKSSON
, O.E. DAHL
, et al.
·
Journal of Thrombosis and Haemostasis
·
414
Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement
2005
·
B.I. ERIKSSON
, L. BORRIS
, et al.
·
Journal of Thrombosis and Haemostasis
·
301
Prolonged Thromboprophylaxis Following Hip Replacement Surgery – Results of a Double-blind, Prospective, Randomised, Placebo-controlled Study with Dalteparin (Fragmin®)
1997
·
O E Dahl
, G Andreassen
, et al.
·
Thrombosis and Haemostasis
·
277
Frequency and timing of clinical venous thromboembolism after major joint surgery
2006
·
B. T. Bjørnar̊
, T. E. Gudmundsen
, et al.
·
Journal of Bone and Joint Surgery - British Volume
·
215
PDF
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I
2004
·
B.I. Eriksson
, O.E. Dahl
, et al.
·
Journal of Thrombosis and Haemostasis
·
202
PDF
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study
2003
·
B.I. Eriksson
, G. Agnelli
, et al.
·
Journal of Thrombosis and Haemostasis
·
197
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials
2010
·
R.J. Friedman
, O.E. Dahl
, et al.
·
Thrombosis Research
·
142
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery
2007
·
D.J. QUINLAN
, J.W. EIKELBOOM
, et al.
·
Journal of Thrombosis and Haemostasis
·
114
Safety assessment of new antithrombotic agents: Lessons from the EXTEND study on ximelagatran
2008
·
G. Agnelli
, B.I. Eriksson
, et al.
·
Thrombosis Research
·
93
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty
2010
·
O.E. DAHL
, D.J. QUINLAN
, et al.
·
Journal of Thrombosis and Haemostasis
·
80
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study
2008
·
B.I. ERIKSSON
, O.E. DAHL
, et al.
·
Journal of Thrombosis and Haemostasis
·
66
Orthopaedic thromboprophylaxis
2008
·
D. Warwick
, O. E. Dahl
, et al.
·
Journal of Bone and Joint Surgery - British Volume
·
53
No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture.A prospective randomized study on 334 patients over 75 years
2013
·
O. Talsnes
, F. Hjelmstedt
, et al.
·
Archives of Orthopaedic and Trauma Surgery
·
52
Intrapulmonary thrombin generation and its relation to monomethylmethacrylate plasma levels during hip arthroplasty
1992
·
O. E. Dahl
, H. Johnsen
, et al.
·
Acta Anaesthesiologica Scandinavica
·
47
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery – TREK: a dose-ranging study
2009
·
M.R. LASSEN
, O.E. DAHL
, et al.
·
Journal of Thrombosis and Haemostasis
·
45
PDF
The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs
1995
·
O. E. Dahl
, T. Aspelin
, et al.
·
Blood Coagulation & Fibrinolysis
·
44
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin
2003
·
H. Arnesen
, O.E. Dahl
, et al.
·
Journal of Thrombosis and Haemostasis
·
39
PDF
Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement
2003
·
O.E. Dahl
, A.M. Pleil
·
Journal of Thrombosis and Haemostasis
·
32
Update of the recommendations on biosimilar low‐molecular‐weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis
2013
·
J. Harenberg
, J. Walenga
, et al.
·
Journal of Thrombosis and Haemostasis
·
16
PDF
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use.
2008
·
O E Dahl
, L C Borris
, et al.
·
PubMed
·
14
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders
2012
·
Dahl OE
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
7
Divergent regional opinions on thromboembolic complications and prophylaxis among surgeons
2004
·
O.E. Dahl
·
Journal of Thrombosis and Haemostasis
·
5
Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions - a topic for emotions?
2000
·
O. E. Dahl
·
European Journal of Anaesthesiology
·
5
PDF
[The bone cement implantation syndrome].
1984
·
O E Dahl
·
PubMed
·
3
Show more works
View as search
Works count:
45
Citation count:
3,450
H-index:
19
I10-index:
21
Year
Topic
Type
